z-logo
open-access-imgOpen Access
Can knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?
Author(s) -
Daniel J. Crona,
Federico Innocenti
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/bjs5-rs38
Subject(s) - dosing , germline , toxicity , medicine , oncology , pharmacology , cancer research , biology , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here